— Know what they know.
Not Investment Advice

CRDF NASDAQ

Cardiff Oncology, Inc.
1W: +3.5% 1M: +3.5% 3M: +11.2% YTD: -32.7% 1Y: -41.7% 3Y: +5.3% 5Y: -79.1%
$1.78
-0.01 (-0.56%)
 
Weekly Expected Move ±8.2%
$1 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 50 · $121.7M mcap · 67M float · 1.17% daily turnover · Short 43% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
35.7 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 310.1%
Cost Advantage
34
Intangibles
30
Switching Cost
49
Network Effect
34
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CRDF has No discernible competitive edge (35.7/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. ROIC of 310.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 3Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CRDF receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-04-01 C C-
2026-02-27 C+ C
2026-01-03 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

21 Grade D
Profitability
0
Balance Sheet
90
Earnings Quality
39
Growth
47
Value
30
Momentum
49
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CRDF scores highest in Balance Sheet (90/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-7.34
Distress Zone
Piotroski F-Score
2/9
Beneish M-Score
-0.65
Possible Manipulator
Ohlson O-Score
-1.88
Bankruptcy prob: 13.3%
Moderate
Credit Rating
BB
Score: 43.7/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.84x
Accruals: -9.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CRDF scores -7.34, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CRDF scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CRDF's score of -0.65 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CRDF's implied 13.3% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CRDF receives an estimated rating of BB (score: 43.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.72x
PEG
-0.07x
P/S
231.81x
P/B
3.51x
P/FCF
-2.96x
P/OCF
EV/EBITDA
-1.17x
EV/Revenue
101.44x
EV/EBIT
-1.14x
EV/FCF
-1.42x
Earnings Yield
-40.43%
FCF Yield
-33.83%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CRDF currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.958
EBT / EBIT
×
EBIT Margin
-88.975
EBIT / Rev
×
Asset Turnover
0.007
Rev / Assets
×
Equity Multiplier
1.240
Assets / Equity
=
ROE
-69.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CRDF's ROE of -69.8% is driven by Asset Turnover (0.007), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.78
Median 1Y
$0.96
5th Pctile
$0.18
95th Pctile
$5.15
Ann. Volatility
102.4%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Mark Erlander,
CEO
$— $— $2,266,106
Rodger Sidhu, CMO
$— $— $1,920,275
James Levine,
CFO
$— $— $993,875

CEO Pay Ratio

5:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,266,106
Avg Employee Cost (SGA/emp): $458,839
Employees: 31

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
31
-6.1% YoY
Revenue / Employee
$19,129
Rev: $593,000
Profit / Employee
$-1,479,871
NI: $-45,876,000
SGA / Employee
$458,839
Avg labor cost proxy
R&D / Employee
$1,139,645
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -34.0% -37.6% -21.1% -25.4% -28.1% -29.4% -31.4% -31.6% -32.1% -33.1% -47.1% -45.7% -46.4% -48.8% -59.5% -64.0% -66.8% -66.0% -71.5% -69.8% -69.77%
ROA -31.2% -34.4% -19.9% -24.0% -26.6% -27.8% -29.1% -29.3% -29.8% -30.7% -41.9% -40.7% -41.3% -43.5% -50.8% -54.6% -57.1% -56.4% -57.6% -56.3% -56.29%
ROIC 9.4% 10.4% -8.4% -10.0% -11.1% -11.6% -8.3% -8.5% -8.9% -9.3% 12.2% 11.9% 12.0% 12.5% 5.3% 5.7% 5.9% 5.8% 3.2% 3.1% 3.10%
ROCE -18.2% -20.3% -19.8% -23.7% -26.2% -27.6% -36.8% -37.7% -39.3% -41.0% -63.8% -62.2% -62.7% -65.2% -58.1% -62.2% -64.9% -63.3% -1.1% -1.0% -1.03%
Gross Margin 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 24.1% 34.0% 50.2% 35.6% -57.4% 1.0% 1.0% -94.7% 1.0% 1.0% -4.4% -4.39%
Operating Margin -101.3% -81.4% -71.6% -149.6% -114.8% -96.7% -73.4% -145.2% -113.0% -76.7% -66.2% -53.3% -77.0% -76.4% -83.3% -131.9% -122.1% -99.8% -32.2% -313.4% -313.41%
Net Margin -99.4% -80.4% -71.0% -148.6% -114.8% -92.2% -67.9% -135.2% -103.2% -69.0% -59.9% -48.8% -72.3% -71.8% -78.1% -123.2% -115.2% -93.8% -29.7% -301.2% -301.24%
EBITDA Margin -99.7% -80.1% -66.5% -149.2% -114.3% -95.8% -72.7% -144.1% -112.1% -76.0% -65.6% -52.8% -76.3% -75.8% -82.6% -129.9% -121.3% -89.7% -31.3% -308.0% -308.02%
FCF Margin -48.2% -60.6% -64.7% -77.0% -79.4% -84.0% -90.2% -83.7% -81.2% -73.5% -64.5% -50.2% -48.8% -50.3% -55.2% -72.7% -76.7% -84.4% -64.0% -71.4% -71.35%
OCF Margin -47.7% -60.2% -64.2% -75.9% -77.6% -81.4% -87.6% -81.6% -79.3% -72.0% -63.3% -49.1% -48.2% -50.2% -55.1% -72.7% -76.6% -84.3% -64.0% -71.3% -71.27%
ROE 3Y Avg snapshot only -71.74%
ROE 5Y Avg snapshot only -55.22%
ROA 3Y Avg snapshot only -57.30%
ROIC Economic snapshot only -81.08%
Cash ROA snapshot only -60.46%
NOPAT Margin snapshot only -71.37%
Pretax Margin snapshot only -85.27%
R&D / Revenue snapshot only 60.22%
SGA / Revenue snapshot only 24.80%
SBC / Revenue snapshot only 8.20%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -11.19 -10.35 -8.63 -3.14 -2.52 -1.69 -1.62 -1.89 -1.66 -1.52 -1.60 -5.93 -2.44 -2.91 -4.55 -3.06 -4.11 -2.73 -4.10 -2.47 -2.718
P/S Ratio 652.14 762.96 679.70 296.99 248.11 170.67 162.04 186.63 159.41 135.00 135.50 391.12 149.64 181.61 302.34 254.46 383.80 274.99 316.73 210.91 231.806
P/B Ratio 2.01 2.06 1.74 0.76 0.68 0.48 0.59 0.69 0.62 0.58 0.95 3.42 1.43 1.79 2.49 1.80 2.53 1.66 4.14 2.44 3.505
P/FCF -13.53 -12.59 -10.50 -3.86 -3.13 -2.03 -1.80 -2.23 -1.96 -1.84 -2.10 -7.79 -3.06 -3.61 -5.47 -3.50 -5.00 -3.26 -4.95 -2.96 -2.956
P/OCF
EV/EBITDA -5.56 -5.21 -3.82 0.91 1.14 1.81 1.01 0.71 0.87 0.92 0.15 -3.78 -0.61 -1.14 -2.42 -1.15 -2.22 -0.91 -2.76 -1.17 -1.166
EV/Revenue 322.95 386.10 296.13 -84.46 -110.49 -181.51 -103.64 -73.00 -89.51 -87.94 -13.43 271.98 40.36 76.13 170.44 101.02 218.56 94.91 219.82 101.44 101.438
EV/EBIT -5.45 -5.12 -3.76 0.90 1.13 1.80 1.00 0.71 0.86 0.91 0.14 -3.75 -0.60 -1.13 -2.40 -1.14 -2.20 -0.90 -2.70 -1.14 -1.140
EV/FCF -6.70 -6.37 -4.57 1.10 1.39 2.16 1.15 0.87 1.10 1.20 0.21 -5.42 -0.83 -1.51 -3.09 -1.39 -2.85 -1.12 -3.43 -1.42 -1.422
Earnings Yield -8.9% -9.7% -11.6% -31.8% -39.7% -59.1% -61.9% -52.8% -60.4% -65.7% -62.7% -16.9% -41.1% -34.3% -22.0% -32.7% -24.3% -36.6% -24.4% -40.4% -40.43%
FCF Yield -7.4% -7.9% -9.5% -25.9% -32.0% -49.2% -55.7% -44.9% -50.9% -54.4% -47.6% -12.8% -32.6% -27.7% -18.3% -28.6% -20.0% -30.7% -20.2% -33.8% -33.83%
Price/Tangible Book snapshot only 2.440
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 21.79 21.79 22.28 22.28 22.28 22.28 14.25 14.25 14.25 14.25 7.41 7.41 7.41 7.41 7.08 7.08 7.08 7.08 3.67 3.67 3.668
Quick Ratio 21.79 21.79 22.28 22.28 22.28 22.28 14.25 14.25 14.25 14.25 7.41 7.41 7.41 7.41 7.08 7.08 7.08 7.08 3.67 3.67 3.668
Debt/Equity 0.01 0.01 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.018
Net Debt/Equity -1.02 -1.02 -0.98 -0.98 -0.98 -0.98 -0.96 -0.96 -0.96 -0.96 -1.04 -1.04 -1.04 -1.04 -1.09 -1.09 -1.09 -1.09 -1.27 -1.27 -1.266
Debt/Assets 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.013
Debt/EBITDA -0.04 -0.03 -0.11 -0.09 -0.08 -0.08 -0.07 -0.07 -0.06 -0.06 -0.05 -0.05 -0.05 -0.05 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.018
Net Debt/EBITDA 5.67 5.08 4.95 4.10 3.70 3.51 2.59 2.53 2.42 2.33 1.61 1.66 1.64 1.58 1.87 1.75 1.68 1.73 1.22 1.26 1.258
Interest Coverage -15411.59 -17146.29
Equity Multiplier 1.05 1.05 1.06 1.06 1.06 1.06 1.09 1.09 1.09 1.09 1.17 1.17 1.17 1.17 1.17 1.17 1.17 1.17 1.36 1.36 1.363
Cash Ratio snapshot only 3.556
Cash to Debt snapshot only 70.077
FCF to Debt snapshot only -45.025
Defensive Interval snapshot only 590.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.007
Inventory Turnover
Receivables Turnover 1.51 1.32 0.84 0.84 0.90 0.91 0.59 0.60 0.63 0.70 0.92 1.15 1.26 1.30 1.29 1.11 1.03 0.94 1.24 1.10 1.099
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.11 0.16 0.21 5.07 2.90 2.87 6.25 3.41 1.79 1.83 1.828
DSO 242 277 435 432 406 399 617 603 579 518 396 317 291 281 283 329 355 386 294 332 332.0 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 5791 3408 2294 1716 72 126 127 58 107 203 200 199.6 days
Cash Conversion Cycle -5272 -3012 -1977 -1426 209 157 202 296 280 90 132 132.4 days
Fixed Asset Turnover snapshot only 0.435
Cash Velocity snapshot only 0.009
Capital Intensity snapshot only 117.874
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 54.8% 1.7% -2.0% -2.5% -2.8% 13.2% 7.5% 9.4% 7.3% 17.6% 26.4% 54.4% 61.4% 49.8% 40.2% -3.6% -17.9% -27.3% -13.3% -10.7% -10.71%
Net Income -38.8% -50.1% -46.5% -67.2% -64.1% -55.0% -36.8% -14.2% -4.9% -3.4% -7.1% -3.3% -3.1% -5.3% -9.6% -21.4% -24.9% -17.3% -0.9% 8.4% 8.36%
EPS 48.1% 11.4% 15.8% -43.7% -46.9% -41.5% -24.3% -10.5% -1.7% -0.3% -7.1% -3.3% -2.7% -0.4% -2.8% -13.9% 15.9% 17.8% 28.1% 36.1% 36.12%
FCF -34.8% -43.8% -40.7% -45.9% -60.1% -57.0% -49.8% -19.0% -9.7% -2.8% 9.6% 7.4% 2.9% -2.6% -20.0% -39.6% -29.0% -22.0% -0.5% 12.4% 12.37%
EBITDA -95.5% -1.2% -47.8% -66.5% -62.0% -53.2% -42.5% -20.9% -13.7% -12.5% -13.5% -8.1% -4.5% -4.3% -7.2% -17.5% -21.7% -13.2% 2.2% 11.4% 11.42%
Op. Income -38.7% -53.0% -51.2% -69.0% -64.0% -55.0% -38.3% -18.5% -12.1% -11.1% -13.8% -8.3% -4.7% -4.4% -7.1% -17.6% -21.7% -15.7% -0.6% 9.0% 8.97%
OCF Growth snapshot only 12.47%
Asset Growth snapshot only -36.33%
Equity Growth snapshot only -45.28%
Debt Growth snapshot only -45.37%
Shares Change snapshot only 43.44%
Dividend Growth snapshot only -1.00%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -8.8% -10.7% -1.7% -6.4% -6.3% -3.1% -4.6% 4.1% 17.3% 10.6% 10.0% 18.1% 18.9% 25.9% 24.0% 17.7% 12.4% 8.6% 15.4% 9.9% 9.95%
Revenue 5Y 1.9% -2.5% -1.2% 0.3% 1.6% 0.1% -5.2% -5.0% -4.6% -1.1% 5.2% 6.7% 7.4% 9.9% 9.0% 10.9% 16.4% 8.1% 10.1% 7.2% 7.23%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 1.3% -8.8% -7.0% -14.4%
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 1.2% 1.2% 1.2% 1.2% 1.2% 1.2% 1.1% 1.1% 1.1% 1.1% -15.4% -15.4% -15.4% -15.4% -13.4% -13.4% -13.4% -13.4% -18.9% -18.9% -18.94%
Assets 5Y 13.5% 13.5% 27.8% 27.8% 27.8% 27.8% 56.7% 56.7% 56.7% 56.7% 41.9% 41.9% 41.9% 41.9% 49.3% 49.3% 49.3% 49.3% -14.4% -14.4% -14.41%
Equity 3Y 1.7% 1.7% 1.4% 1.4% 1.4% 1.4% 1.4% 1.4% 1.4% 1.4% -18.4% -18.4% -18.4% -18.4% -16.1% -16.1% -16.1% -16.1% -24.7% -24.7% -24.71%
Book Value 3Y -14.3% 19.6% 9.5% 9.6% 20.3% 24.6% 39.4% 47.8% 67.7% 96.6% -34.2% -23.2% -22.2% -22.8% -20.5% -18.8% -27.3% -27.4% -34.2% -34.7% -34.66%
Dividend 3Y 47.6% 56.4% 77.5% 1.1% -80.4% -77.1% -76.8% -77.1% -5.2% -3.2% -13.3%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.04 0.25 0.04 0.02 0.00 0.10 0.77 0.44 0.09 0.02 0.40 0.21 0.21 0.42 0.41 0.73 0.77 0.54 0.73 0.56 0.555
Earnings Stability 0.34 0.35 0.19 0.01 0.02 0.17 0.44 0.72 0.85 0.88 0.92 0.92 0.90 0.91 0.96 0.95 0.92 0.91 0.89 0.81 0.810
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.84 0.50 0.81 0.50 0.50 0.50 0.85 0.94 0.98 0.99 0.97 0.99 0.99 0.98 0.96 0.91 0.90 0.93 1.00 0.97 0.967
Earnings Smoothness
ROE Trend 1.75 1.77 1.00 0.97 0.96 0.98 -0.19 -0.17 -0.15 -0.14 -0.31 -0.27 -0.26 -0.28 -0.07 -0.12 -0.14 -0.11 -0.44 -0.40 -0.403
Gross Margin Trend 651.34 704.18 9.34 8.06 5.52 0.00 0.00 0.00 0.00 -0.23 -0.43 -0.51 -0.63 -14.32 -14.18 -16.32 -38.55 -15.78 -12.11 -13.94 -13.936
FCF Margin Trend -5.62 -23.29 -27.26 -32.30 -27.63 -32.30 -35.29 -19.54 -17.40 -1.12 13.00 30.14 31.46 28.45 22.13 -5.73 -11.68 -22.49 -4.17 -9.90 -9.905
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.82 0.82 0.81 0.80 0.79 0.81 0.87 0.83 0.82 0.81 0.75 0.74 0.78 0.80 0.83 0.87 0.82 0.84 0.83 0.84 0.836
FCF/OCF 1.01 1.01 1.01 1.01 1.02 1.03 1.03 1.03 1.02 1.02 1.02 1.02 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.001
FCF/Net Income snapshot only 0.837
CapEx/Revenue 53.6% 45.2% 57.1% 1.0% 1.8% 2.7% 2.6% 2.1% 1.9% 1.4% 1.2% 1.1% 60.6% 12.8% 11.7% 0.0% 4.8% 8.8% 7.4% 8.4% 8.38%
CapEx/Depreciation snapshot only 0.043
Accruals Ratio -0.06 -0.06 -0.04 -0.05 -0.06 -0.05 -0.04 -0.05 -0.05 -0.06 -0.11 -0.10 -0.09 -0.09 -0.09 -0.07 -0.10 -0.09 -0.10 -0.09 -0.092
Sloan Accruals snapshot only -0.489
Cash Flow Adequacy snapshot only -850.386
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.7% 0.6% 0.6% 0.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0
Chowder Number 16.26 16.26 16.26 16.51 -0.99 -0.99 -0.99 -0.99 0.00 0.00 0.00
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -49.2% -43.5% -14.5% -31.9% -15.7% -22.5% -0.1% -0.1% -0.1% 0.0% 0.0% -0.0% -2.2% -7.7% -26.0% -35.9% -24.6% -32.1% -1.4% -2.4% -2.40%
Total Shareholder Return -49.2% -43.5% -14.5% -31.9% -15.7% -22.5% 0.5% 0.5% 0.5% 0.7% 0.0% -0.0% -2.2% -7.7% -26.0% -35.9% -24.6% -32.1% -1.4% -2.4% -2.40%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.98 0.98 1.00 1.01 1.01 1.00 0.97 0.95 0.93 0.92 0.91 0.91 0.92 0.93 0.93 0.94 0.94 0.95 0.95 0.96 0.958
EBIT Margin -59.23 -75.44 -78.81 -93.97 -97.60 -100.95 -103.37 -103.49 -103.51 -96.68 -93.06 -72.61 -67.11 -67.36 -71.13 -88.61 -99.51 -105.77 -81.36 -88.98 -88.975
Asset Turnover 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.007
Equity Multiplier 1.09 1.09 1.06 1.06 1.06 1.06 1.08 1.08 1.08 1.08 1.12 1.12 1.12 1.12 1.17 1.17 1.17 1.17 1.24 1.24 1.240
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.59 $-0.64 $-0.70 $-0.79 $-0.87 $-0.91 $-0.87 $-0.87 $-0.89 $-0.91 $-0.93 $-0.90 $-0.91 $-0.92 $-0.95 $-1.03 $-0.77 $-0.75 $-0.69 $-0.65 $-0.65
Book Value/Share $3.31 $3.24 $3.46 $3.25 $3.24 $3.24 $2.38 $2.38 $2.38 $2.38 $1.56 $1.56 $1.56 $1.49 $1.74 $1.74 $1.25 $1.24 $0.68 $0.66 $0.51
Tangible Book/Share $3.31 $3.24 $3.46 $3.25 $3.24 $3.24 $2.38 $2.38 $2.38 $2.38 $1.56 $1.56 $1.56 $1.49 $1.74 $1.74 $1.25 $1.24 $0.68 $0.66 $0.66
Revenue/Share $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01
FCF/Share $-0.49 $-0.53 $-0.57 $-0.64 $-0.70 $-0.76 $-0.78 $-0.74 $-0.75 $-0.76 $-0.70 $-0.69 $-0.72 $-0.74 $-0.79 $-0.90 $-0.63 $-0.63 $-0.57 $-0.55 $-0.55
OCF/Share $-0.49 $-0.53 $-0.57 $-0.63 $-0.69 $-0.73 $-0.76 $-0.72 $-0.73 $-0.74 $-0.69 $-0.67 $-0.72 $-0.74 $-0.79 $-0.90 $-0.63 $-0.63 $-0.57 $-0.55 $-0.55
Cash/Share $3.38 $3.31 $3.47 $3.26 $3.25 $3.25 $2.36 $2.36 $2.36 $2.36 $1.67 $1.67 $1.67 $1.60 $1.93 $1.93 $1.38 $1.37 $0.87 $0.85 $0.67
EBITDA/Share $-0.59 $-0.65 $-0.69 $-0.78 $-0.86 $-0.90 $-0.89 $-0.91 $-0.95 $-0.99 $-1.01 $-0.98 $-0.99 $-0.98 $-1.01 $-1.08 $-0.81 $-0.78 $-0.71 $-0.67 $-0.67
Debt/Share $0.02 $0.02 $0.08 $0.07 $0.07 $0.07 $0.06 $0.06 $0.06 $0.06 $0.05 $0.05 $0.05 $0.05 $0.03 $0.03 $0.02 $0.02 $0.01 $0.01 $0.01
Net Debt/Share $-3.36 $-3.29 $-3.39 $-3.19 $-3.18 $-3.18 $-2.30 $-2.30 $-2.30 $-2.30 $-1.63 $-1.63 $-1.62 $-1.55 $-1.89 $-1.89 $-1.36 $-1.35 $-0.86 $-0.84 $-0.84
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -7.336
Altman Z-Prime snapshot only -16.042
Piotroski F-Score 4 4 3 3 3 4 2 2 2 2 3 2 2 2 4 3 2 3 2 2 2
Beneish M-Score -2.13 -1.92 -2.24 -2.37 -2.32 -2.30 0.30 0.19 0.09 1.87 -2.47 -1.92 -2.19 -3.81 -1.96 -0.32 -1.44 -31.82 1.20 -0.65 -0.653
Ohlson O-Score snapshot only -1.877
ROIC (Greenblatt) snapshot only -1.04%
Net-Net WC snapshot only $0.64
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 60.96 61.06 74.12 74.77 75.45 58.17 49.48 49.39 49.20 49.67 44.65 76.44 44.41 44.61 65.03 50.10 60.00 44.33 44.03 43.66 43.664
Credit Grade snapshot only 12
Credit Trend snapshot only -6.437
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 39
Sector Credit Rank snapshot only 36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms